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Abstract: 
Background: 
Prediction models for trauma outcome routinely control for age but there is uncertainty about 
the need to control for comorbidity and whether the two interact. This paper describes recent 
revisions to the Trauma Audit and Research Network (TARN) risk adjustment model 
designed to take account of age and comorbidities. In addition linkage between TARN and 
the Office of National Statistics (ONS) database allows patient’s outcome to be accurately 
identified up to 30 days after injury. Outcome at discharge within 30 days was previously 
used. 
 
Methods: 
Prospectively collected data between 2010 and 2013 from the TARN database were analysed. 
The data for modelling consisted of 129 786 hospital trauma admissions. Three models were 
compared using the area under the receiver operating curve (AuROC) for assessing the ability 
of the models to predict outcome, the Akaike information criteria to measure the quality 
between models and test for goodness-of-fit and calibration. Model 1 is the current TARN 
model, Model 2 is Model 1 augmented by a modified Charlson comorbidity index and Model 
3 is Model 2 with ONS data on 30 day outcome. 
 
Results: 
The values of the AuROC curve for Model 1 were 0.896 (95% CI 0.893 to 0.899), for Model 
2 were 0.904 (0.900 to 0.907) and for Model 3 0.897 (0.896 to 0.902). No significant 
interaction was found between age and comorbidity in Model 2 or in Model 3 
 
Conclusions: 
The new model includes comorbidity and this has improved outcome prediction. There was 
no interaction between age and comorbidity, suggesting that both independently increase 
vulnerability to mortality after injury. 
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WHAT THIS PAPER ADDS 
 
What is already known on this subject? 
 
• The trauma population is getting older and the incidence of pre-existing diseases is 
rising but the interaction between age and comorbidity is unclear. 
 
• Outcome prediction models are useful in the assessment of patient care and system 
development. However, the complexities of data collection and the lack of a 
comorbidity scale designed specifically for the trauma population limits their 
applicability to the new trauma demographic. 
 
What this study adds 
 
• The incorporation of a modification of the Charlson comorbidity index into our 
outcome prediction model improved its performance; using data linkage to measure 
30 day outcome on all patients did not. 
 
• There was no significant interaction between age and comorbidity; both appear to be 
independent and separate influences on outcome. 
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Background 
Trauma is a global disease affecting people of all ages and the leading cause of death in the 
first four decades of life. Care is improving [1, 2] but in order to understand the relative 
effectiveness of individual patient treatment and of trauma systems generally it is necessary 
to develop outcome prediction models and apply them to large data sets in trauma registries. 
The development of the trauma score/injury severity score methodology [3, 4] has been 
pivotal to these advances. This and other prediction models have been reported recently in a 
systematic review. [5] 
 
The trauma population in the UK is ageing; the average age of patients on the Trauma Audit 
and Research Network (TARN) database has increased from 47 years to 57 years since 
2008.[6] Recorded comorbidity has also increased in the same period, from 37% to 62%.[6] 
It therefore seems appropriate to include comorbidity in addition to age as a risk factor in 
outcome prediction models. Previous work suggests that comorbidity and age are 
independently associated with increased mortality after trauma but has not examined their 
interaction.[7-9] A presence of interaction would mean that the effect of comorbidity on 
outcome is highly dependent of patient’s age, for example, the impact of the presence of a 
serious comorbidity in reducing odds of survival after injury, could be higher in a younger 
patient than an older patient, or vice versa - if an interaction is present. If there is no 
interaction the relative reduction in odds of survival associated with serious comorbidity is 
the same regardless of patient age. 
 
The outcome prediction model currently used by TARN [6] defines survival as either ‘alive at 
hospital discharge’ or ‘alive in hospital at 30 days’; there is no accounting for the outcome of 
those discharged alive before 30 days.[10] The model is ‘casemix adjusted’ using age, gender 
(and their interaction), injury severity score (ISS) and GCS as predictors. The 30-day 
threshold is considered appropriate because later death is less likely to be associated directly 
with the injuries which prompted hospital admission. However, including all deaths up to 30 
days (not just those occurring in hospital up to 30 days) has been proposed as being more 
logical, despite demanding more complex data acquisition. [11] 
 
This paper describes a new prediction model which uses ‘30 day outcome’ for all patients 
rather than just those still in hospital and incorporates a new comorbidity measure. It 
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investigates the interaction between age and comorbidity and compares the new model’s 
performance with that currently used by TARN for trauma quality assurance within England 
and Wales, Republic of Ireland and some hospitals in continental Europe. 
 
Patients and Methods 
The TARN database is the largest trauma registry in Europe, holding data from all trauma 
receiving hospitals in England and Wales and some in Denmark, Switzerland and the 
Republic of Ireland. Patients of all ages are included on the database if they sustain injury 
resulting in any of: immediate admission to hospital for 3 days or longer, intensive or high 
dependency care, inter-hospital transfer for further care or death in hospital within 30 days. 
Patients aged over 65 years with an isolated fracture of the femoral neck or pubic ramus and 
those with isolated closed limb injuries (excepting the femoral shaft/condyles) are excluded. 
If transfers can be matched using data from both hospitals, these are linked for one patient to 
avoid duplication. Transfers out of the first hospital without a linked submission from a 
receiving hospital are excluded from mortality analyses.  
 
Prospectively collected data were used in the current cohort study which includes eligible 
patients submitted to TARN from 1 January 2010 to 31 December 2013; presenting with 
blunt or penetrating trauma during those dates. A matching exercise was conducted in an 
attempt to obtain the records of patients transferred to a second hospital for specialist care. 
Where matching could not be accomplished the patients were excluded. The characteristics of 
the excluded and included patients were compared. 
 
Comorbidity 
Various comorbidity indices have been used in outcome prediction models. The Charlson 
comorbidity index (CCI) is one of the most frequently used as demonstrated in a recent 
systematic review. [12] CCI uses weighted International Classification of Diseases (ICD) 10 
based diagnoses summed to give a score for each patient. The original weights [13] were 
updated by Dr Foster Intelligence in 2011 and incorporated into the hospital standardised 
mortality ratio. [14] The CCI was also used in the recently developed Summary Hospital 
Mortality Index. [15] 
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The original 17 Charlson codes were developed from a sample of 559 patients; [13] these did 
not cover the whole spectrum of medical conditions seen in trauma patients. The comorbidity 
dictionary separately developed earlier by TARN, and also based on ICD 10, contained many 
additional diagnoses. An extensive mapping exercise was therefore carried out to convert the 
TARN data points to Charlson compatible data points. The wider reach of the TARN data 
required the creation of five new groups which had not been represented in the original 
Charlson codes (in bold in table 1). 
 
The resulting 22 conditions were used as binary factors along with age and gender in a 
logistic regression model to derive the weights of each comorbidity group within the patients 
used for this study. The weights were obtained by dividing each of the regression coefficients 
by the coefficient with the smallest absolute value and then rounded up to the nearest whole 
number. [16] The comorbidity index derived from this exercise can be described as a 
modified version of the original CCI and is therefore denoted as ‘mCCI’. 
Outcomes at 30 days 
TARN does not hold data on patients’ outcome after hospital discharge. The Office of 
National Statistics (ONS) database does have such information and permission was given to 
carry out a data linkage exercise to obtain the outcome at 30 days after admission for all 
TARN registered patients (defined as ‘true’ 30 day outcome). The results were compared 
with the current TARN model [7] which is based on a model using outcome at 30 days from 
admission or at discharge, whichever comes first. 
 
Missing Data 
The GCS was not recorded in 10% of the selected cases. Previous studies [17] have suggested 
that these patients are often the more seriously injured and must be included in the analyses. 
An imputation technique, based on chained equations and Rubin's rules, was therefore used 
on the assumption that the mechanism of missingness is random.[18] Age, gender, mCCI and 
GCS were used as categorical variables. When GCS was missing for a specific non-random 
reason, for example, intubation, an extra category was added to GCS accordingly.  
Comorbidity status was not recorded in 16% of patients. These were identified by adding a 
‘missing’ category to the mCCI variable. 
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Statistical analysis 
Three statistical models were compared each on the same number of TARN cases where the 
outcome from the last acute hospital was known.  
 
• Model 1 represents the current TARN model. It uses age and gender and their 
interaction, ISS, GCS and outcome at 30 days or at discharge, whichever comes first; 
[7] 
 
• Model 2 is the same as Model 1 with the addition of the TARN mCCI; 
 
• Model 3 is the same as Model 2 but using ‘true’ outcome at 30 days from admission 
as the dependent variable. 
 
The outcome prediction models are based on multiple logistic regressions using age, gender, 
ISS, GCS, mCCI and age by gender interaction as predictors. The non-linearity of the ISS 
was corrected using fractional polynomials (FPs) [7] to enable its inclusion in the logistic 
regression model, [7] and was used as a continuous variable in the model, whereas age (eight 
levels), gender (two levels), age by gender interaction, GCS (seven levels) and mCCI (five 
levels) were used as categorical variables. The significance of the interaction between age 
and comorbidity was also assessed.  
 
All the analyses were performed with Stata V.13.0 and R software. [19, 20] 
 
Validation 
An internal validation for the model was carried out using a bootstrap [21] procedure where 
200 samples of the same size as the original data set were drawn with replacement using the 
library ‘bootstrap’ from the R package. [20] The advantage of this procedure over split 
sample cross validation is that model performance and calibration are assessed in the original 
sample using the models developed in the bootstrap samples. A model which is developed on 
the whole sample produces stable estimates of the regression coefficients. [22] 
 
Model performance or discriminant power was assessed through the area under the receiver 
operating curve (AuROC). Model calibration was assessed using calibration graphs instead of 
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the Hosmer-Lemeshow (H-L) test. [23] While the Hosmer-Lemeshow (H-L) test does not 
demonstrate poor calibration it is too sensitive with large sample sizes—any tiny deviation 
from perfect fit is detected. The same bootstrap technique used previously for the validation 
of the models was used to internally validate the modified Charlson weights.  
 
TARN holds Health Research Authority Confidentiality Advisory Group (CAG) Section 251 
approval. 
 
Results 
In the 4 years studied 129,786 patients meeting the TARN inclusion criteria from 207 trauma 
receiving hospitals were recorded with known outcomes; 10,810 patients were excluded 
because of unknown outcome after hospital transfer. Excluded patients were younger (51 
years vs 57 years), more severely injured (ISS 16 vs 9), more likely to be male (68% vs 59%) 
but had similar GCS and comorbidity distributions (table 2). The characteristics of the 
patients used for the model derivation are shown in table 2. 
 
The sample mortality rate was 7%, median age 57 years, median ISS 9 and median GCS 15. 
Fifty-nine per cent of patients were male. More than 50% of the patients in the sample were 
recorded as having comorbidity; in 16% the comorbidity status was not recorded. Figure 1 
shows the functional form of ISS on outcome (death) after FP transformation where the 
optimal powers obtained are (−0.5) and (0), representing the reciprocal of the square root and 
the (natural) logarithm of ISS, respectively. Female gender was associated with lower 
survival but as there was a significant interaction between age and gender which identified 
poorer survival in men than women over 65 years, the main effect for gender cannot be 
interpreted independently from age. 
 
The data linkage between TARN and ONS enabled the determination of the true final 
outcome of all patients within 30 days of admission. Five hundred and seventy-two patients 
died after discharge but within 30 days of admission; their characteristics are shown in table 
3. The average age was 84 years, the GCS normal and the ISS low; the majority was female 
and most had a recorded comorbidity. 
 
9 
 
Each of the outcome predictors was significant in each of the models. Model 2, incorporating 
our modification of the CCI, showed better prediction performance than Model 1 and Model 
3. Model 2 was found to have a Brier score of 0.0451, demonstrating a good calibration and 
goodness-of-fit and validating the use of bootstrap simulation in its calibration. Model 2 also 
showed a significantly better discriminant power by means of AuROC=0.904 (95% CI 0.901 
to 0.907, p value <0.001). The comparison between the three models is displayed in table 4. 
 
The regression coefficients of Model 2 are shown in table 5; the effect of mCCI on outcome 
for the category ‘not known’ is similar to that of the ‘1–5’ group. Patients in this ‘not known’ 
category were younger (median age 48 years vs 65 years) but had similar median ISS and 
GCS. 
 
The effects of the age/comorbidity interaction terms were not statistically significant; this is 
shown in figure 2 where the effect of mCCI on outcome is not modified by age. 
 
Discussion 
We have augmented our trauma score/injury severity score based trauma outcome prediction 
model and shown that the incorporation of a modified comorbidity index significantly 
improves its prediction power (in terms of AuROC and other model performance statistics) 
for survival to discharge from acute care. Incorporating 30 day outcome data on all patents 
through data linkage was possible in 80% of cases. However, this did not improve outcome 
prediction. No significant interaction was found between age and comorbidity in their effect 
on survival to discharge.  
 
The model retains the FP transformations of the ISS that we previously published. [7] It also 
preserves the interaction between age and gender and suggests that increasing age and male 
gender related frailty independently predict adverse rates of survival after adjustment for 
comorbidity.  
 
Some studies have shown that prediction of outcome after trauma has improved by including 
pre-existing medical conditions in models [10,11] but one study found no benefit by adding 
the CCI and commented that the index was not developed specifically for trauma. [24] In our 
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study we have modified the original CCI and recalculated the weights specifically for trauma 
patients.  
 
Two scoring components were examined in our study: the outcome at 30 days from 
admission for all patients, not just those remaining in hospital, and comorbidity using a 
modification of the CCI. Having demonstrated the added prognostic value of our ‘Model 2’, 
which incorporates comorbidity but not comprehensive 30 day outcomes, we have now 
adopted it in the TARN registry. We have updated the major trauma survival probability 
calculator for individual patients on our website [6] and incorporated it in our institutional 
comparisons.  
 
Strengths and limitations 
Our study has a number of strengths. The data were extracted from the TARN database which 
is the largest registry in Europe; it uses standardised and centralised data coding and includes 
all hospitals in England and Wales and some in Denmark, Switzerland and the Republic of 
Ireland. Our outcome prediction models have shown good performance in terms of 
discrimination, calibration and internal validation.  
 
There are some limitations. The outcome status of 8.3% of patients was not known. This is 
chiefly due to patients being transferred to other hospitals and lost to follow-up. Selection 
bias analysis showed that excluded patients were more severely injured; this is often the case 
with patients transferred to specialised centres. The effect of excluded patients on the model's 
performance cannot be assessed as their final outcome is unknown. However, transferred 
patents are referred for specialist and hopefully more effective care; this could impact on their 
outcome and therefore on the model's predictive power.  
The problem of missing GCS data has been overcome by using the multiple imputation 
technique available in Stata. 
 
Missing comorbidity data (16%) is recognised by creating a special category in the mCCI. 
Data linkage was successful in 80% of cases; failure to match the remainder was due to 
invalid patient identification numbers.  
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External validation of our models is currently being conducted in a collaborative project with 
the German trauma registry. This work will also compare our models with the model recently 
developed by the German trauma registry team. [25] This uses a wider range of variables than 
the TARN model and represents the totality of sustained trauma with the worst and the 
second worst injuries rather than ISS. Risk Injury Severity Classification (RISK) II showed a 
good discrimination (AuROC=0.953) albeit in a more severely injured trauma population 
when compared with TARN. [25] 
 
Conclusion 
The accuracy of trauma outcome predictions, as assessed by the AuROC, was improved by 
adding comorbidity to the current TARN ‘survival to discharge’ model. However, using data 
linkage to derive 30 days postadmission outcome status for all patients and including this 
with comorbidity did not improve the model's accuracy; analysis of deaths after hospital 
discharge showed that they do not relate to severity of injury. We did not find a statistically 
significant interaction between comorbidity and age. If our data set is representative of the 
wider trauma population it suggests that both factors predict outcome after major injury 
independently. 
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Table 1.  Modified Charlson comorbidity index with updated weights 
Conditions n Weights 
Not classified 3,177 0 
Other conditions 29,723 0 
Acute Myocardial Infarction 5,111 4 
Cerebral Vascular Accident 5,019 1 
Congestive Heart failure 7,435 5 
Connective Tissue Disorder 10,369 0 
Dementia 5,903 4 
Diabetes 8,993 0 
Liver Disease 1,312 13 
GU Diseases/ Peptic Ulcer 3,277 0 
Peripheral Vascular Disease 2,201 2 
Pulmonary Disease 13,123 0 
Cancer 4,167 3 
Paraplegia 199 0 
Renal Disease 2,293 6 
Metastatic Cancer 480 9 
HIV 176 0 
Mental Health 49,847 0 
Blood Disease 2,312 2 
Bone Disease 5,453 0 
Neurological disorders 4,325 0 
Alcohol Abuse 9,415 4 
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Table 2. Characteristics of the patients. 2010 -2013  
    Outcome  within 30 days from admission 
Total 
included 
  
    Dead Alive   
    Recorded GCS Missing GCS Recorded GCS Missing GCS 
Excluded cases 
with missing 
outcome 
  N 8658 958 106211 13959 129786 10810 
Age Median(IQR†) 77.8 (53.1 - 86.7) 66.3 (43.8 - 80.4) 56.2 (34.3 - 75.7) 48.4 (24.6 - 66.7) 56.6 (34.1 - 76.6) 51 (30 - 70) 
ISS Median(IQR†) 25 (12 - 29) 25 (16 - 26) 9 (9 - 16) 9 (9 - 16) 9 (9 - 17) 16 (9 - 25) 
GCS Median(IQR†) 12 (3 - 15)   15 (15 - 15)   15 (15 - 15) 15 (13 - 15) 
Gender 
Male n (%) 5021 (58%) 616 (64.3%) 62114 (58.5%) 8979 (64.3%) 76730 (59.1%) 7372 (68.2%) 
Female n(%) 3637 (42%) 342 (35.7%) 44097 (41.5%) 4980 (35.7%) 53056 (40.9%) 3438 (31.8%) 
Comorbidity 
Yes n(%) 5880 (67.9%) 574 (59.9%) 57438 (54.1%) 6448 (46.2%) 70340 (54.2%) 5802 (53.7%) 
No n(%) 1020 (11.8%) 142 (14.8%) 32121 (30.2%) 4912 (35.2%) 38195 (29.4%) 3397 (31.4%) 
Not recorded n(%) 1758 (20.3%) 242 (25.3%) 16652 (15.7%) 2599 (18.6%) 21251 (16.4%) 1611 (14.9%) 
 †Interquar@le range  
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Table 3.  Characteristics of the patients who died after discharge within 30 days 
from admission 2010 -2013 
 
N 572 
Age Median (IQR†) 84.7 (75.2 - 91.45) 
ISS Median (IQR†) 9 (9 - 17) 
GCS Median (IQR†) 15 (14 - 15) 
Gender 
Male n(%) 238 (41.6%) 
Female n(%) 334 (58.4%) 
Comorbidity 
Yes n(%) 483 (84.5%) 
No n(%) 19 (3.3%) 
Not Known n(%) 70 (12.2%) 
                      †Interquar@le range 
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Table 4. Models comparison     
Models AuROC (95% CI) Brier score R
2
 
Model 1 0.896 (0.893 – 0.899) 0.0456 0.35 
Model 2 0.904 (0.900 – 0.907) 0.0451 0.363 
Model 3 0.897 (0.896 – 0.902) 0.0452 0.352 
 AuROC: Area under the ROC curve; AIC: Akaike information criteria; H-L: Hosmer- Lemeshow  
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Table 5. Coefficents of the prediction model (Model 2) for Outcome 
Predictors Coefficients p-value 
95% CI for Odds 
ratios 
 
-2.79052 <0.001 0.0464 0.0812 
 
 
-2.57574 <0.001 0.0659 0.0879 
GCS=3 -3.79637 <0.001 0.0203 0.0248 
GCS 4 - 5 -2.73865 <0.001 0.0557 0.0751 
GCS 6 - 8 -1.87664 <0.001 0.1361 0.1722 
GCS 9 - 12 -1.29443 <0.001 0.2477 0.3033 
GCS 13 - 14 -0.46062 <0.001 0.5853 0.6801 
GCS 15  (reference) 0       
GCS "Intubated" -2.62397 <0.001 0.0595 0.0884 
CCI NotKnown -0.449 <0.001 0.5919 0.6882 
CCI 0 (reference) 0       
CCI 1 - 5 -0.49572 <0.001 0.5692 0.6519 
CCI 6 - 10 -0.96308 <0.001 0.3474 0.4195 
CCI > 10 -1.59703 <0.001 0.1791 0.2289 
Age 0  - 5 -0.00483 0.977 0.7206 1.3745 
Age 6 - 10 0.25323 0.275 0.8174 2.03 
Age 11 - 15 -0.08435 0.578 0.6825 1.2378 
Age 16 - 44 (reference) 0       
Age 45 - 54 -0.41388 <0.001 0.5795 0.7542 
Age 55 - 64 -0.93229 <0.001 0.3457 0.4482 
Age 65 - 74 -1.58082 <0.001 0.1814 0.2335 
Age >=75 -2.6752 <0.001 0.0621 0.0765 
Gender Male  (reference) 0       
Gender Female -0.17252 0.029 0.7211 0.9821 
Age 0  - 5 x Female -0.13805 0.582 0.5322 1.4255 
Age 6 - 10 x Female 0.43973 0.32 0.6518 3.697 
10 0.8686
ISS
−
( )10log 0.2817ISSe −
20 
 
Age 11 - 15  x Female 0.21675 0.463 0.6961 2.216 
Age 45 - 54 x Female -0.06972 0.6 0.7183 1.211 
Age 55 - 64 x Female 0.17164 0.159 0.935 1.5075 
Age 65 - 74 x Female 0.25829 0.022 1.0376 1.6155 
Age >=75+ x Female 0.3477 <0.001 1.1928 1.6806 
Constant  5.28621 <0.001     
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Figure 1. Fractional polynomials transformation for ISS 
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Figure 2.  
 
 
